Cor Vasa 2020, 62(4):366-372 | DOI: 10.33678/cor.2020.060

(Right ventricle in athletes)

Agáta Jeníšová, Josef Marek, Štěpán Havránek, Aleš Linhart
II. interní klinika kardiologie a angiologie, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice v Praze

The right ventricle plays a crucial role in cardiovascular function in athletes. However, compared to the left ventricle, it often remains neglected. Despite that, arrhytmogenic cardiomyopathy, which affects predominantly the right ventricle, is one of the most frequent causes of morbidity in European athletes. Detection of the right ventricular disease and its differential diagnosis in athletic heart remains difficult. Physiological adaptation to exercise induces significant changes including chamber dilation. Specific criteria are needed to discern between pathology and physiological adaptation. The aim of this review is to summarize the hallmark features of physiological adaptation of the right ven- tricle in athletes. It especially emphasises the role of electrocardiography and imaging methods. Differential diagnosis of especially arrhytmogenic cardiomyopathy and physiologic right heart adaptation in athletes is discussed.

Keywords: Arrhythmogenic right ventricle cardiomyopathy, ECG, Echocardiography, Endurance sport, Right ventricle remodelling

Received: May 30, 2020; Revised: June 9, 2020; Accepted: June 10, 2020; Published: September 16, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jeníšová A, Marek J, Havránek Š, Linhart A. (Right ventricle in athletes). Cor Vasa. 2020;62(4):366-372. doi: 10.33678/cor.2020.060.
Download citation

References

  1. Haddad F, Hunt SA, Rosenthal DN, Murphy DJ. Right Ventricular Function in Cardiovascular Disease, Part I. Circulation 2008;117:1436-1448. Go to original source... Go to PubMed...
  2. D'Ascenzi F, Solari M, Corrado D, et al. Diagnostic Differentiation Between Arrhythmogenic Cardiomyopathy and Athlete's Heart by Using Imaging. JACC Cardiovasc Imaging 2018;11:1327-1339. Go to original source... Go to PubMed...
  3. Corrado D, van Tintelen PJ, McKenna WJ, et al. Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis. Eur Heart J 2020;41:1414-1429. Go to original source...
  4. D'Ascenzi F, Pelliccia A, Solari M, et al. Normative Reference Values of Right Heart in Competitive Athletes: A Systematic Review and Meta-Analysis. J Am Soc Echocardiogr 2017;30:845-858.e2. Go to original source... Go to PubMed...
  5. Chivulescu M, Haugaa K, Lie OH, et al. Right ventricular remodeling in athletes and in arrhythmogenic cardiomyopathy. Scand Cardiovasc J 2018;52:13-19. Go to original source... Go to PubMed...
  6. Levine BD, Baggish AL, Kovacs RJ, et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation 2015;132:e262-e266. Go to original source... Go to PubMed...
  7. Pelliccia A, Maron BJ, Spataro A, et al. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 1991;324:295-301. Go to original source... Go to PubMed...
  8. D'Ascenzi F, Pisicchio C, Caselli S, et al. RV Remodeling in Olympic Athletes. JACC Cardiovasc Imaging 2017;10:385-393. Go to original source... Go to PubMed...
  9. La Gerche A, Claessen G, Dymarkowski S, et al. Exercise--induced right ventricular dysfunction is associated with ventricular arrhythmias in endurance athletes. Eur Heart J 2015;36:1998-2010. Go to original source... Go to PubMed...
  10. Slabý K. Modelová koncepce organizace sportovních prohlídek - oficiální doporučení ČSTL 2015. www.cstl.cz/file/2015/10/koncepce-prohlidek.pdf. Navštíveno: 2. 9. 2020.
  11. Dell'Italia LJ. The right ventricle: anatomy, physiology, and clinical importance. Curr Probl Cardiol 1991;16:653-720. Go to original source... Go to PubMed...
  12. Lorenz CH, Walker ES, Morgan VL, et al. Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson 1999;1:7-21. Go to original source... Go to PubMed...
  13. Leyton RA, Sonnenblick EH. The sarcomere as the basis of Starling's law of the heart in the left and right ventricles. Methods Achiev Exp Pathol 1971;5:22-59.
  14. Churchill TW, Baggish AL. The Right Heart: Acute and Chronic Issues. Curr Treat Options Cardiovasc Med 2017;19:83. Go to original source... Go to PubMed...
  15. La Gerche A, Roberts T, Claessen G. The response of the pulmonary circulation and right ventricle to exercise: exercise-induced right ventricular dysfunction and structural remodeling in endurance athletes (2013 Grover Conference series). Pulm Circ 2014;4:407-416. Go to original source... Go to PubMed...
  16. D'Ascenzi F, Anselmi F, Ceccon C, et al. The acute impact of an ultramarathon on right heart: A 12-lead ECG study. Scand J Med Sci Sports 2020;30:549-555. Go to original source... Go to PubMed...
  17. James CA, Bhonsale A, Tichnell C, et al. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol 2013;62:1290-1297. Go to original source... Go to PubMed...
  18. Zorzi A, De Lazzari M, Mastella G, et al. Ventricular Arrhythmias in Young Competitive Athletes: Prevalence, Determinants, and Underlying Substrate. J Am Heart Assoc 2018;7:e009171. Go to original source... Go to PubMed...
  19. Zorzi A, Perazzolo Marra M, Rigato I, et al. Nonischemic Left Ventricular Scar as a Substrate of Life-Threatening Ventricular Arrhythmias and Sudden Cardiac Death in Competitive Athletes. Circ Arrhythm Electrophysiol 2016;9:e004229. Go to original source... Go to PubMed...
  20. van de Schoor FR, Aengevaeren VL, Hopman MT, et al. Myocardial Fibrosis in Athletes. Mayo Clin Proc 2016;91:1617-1631. Go to original source... Go to PubMed...
  21. Heidbuchel H, La Gerche A. The right heart in athletes. Evidence for exercise-induced arrhythmogenic right ventricular cardiomyopathy. Herzschrittmacherther Elektrophysiol 2012;23:82-86. Go to original source... Go to PubMed...
  22. Drezner JA, Sharma S, Baggish A, et al. International criteria for electrocardiographic interpretation in athletes: Consensus statement. Br J Sports Med 2017;51:704-731. Go to original source... Go to PubMed...
  23. Uberoi A, Stein R, Perez MV, et al. Interpretation of the electrocardiogram of young athletes. Circulation 2011;124:746-757. Go to original source... Go to PubMed...
  24. Marek J, Bufalino V, Davis J, et al. Feasibility and findings of large-scale electrocardiographic screening in young adults: data from 32,561 subjects. Heart Rhythm 2011;8:1555-1559. Go to original source... Go to PubMed...
  25. Zaidi A, Ghani S, Sheikh N, et al. Clinical significance of electrocardiographic right ventricular hypertrophy in athletes: comparison with arrhythmogenic right ventricular cardiomyopathy and pulmonary hypertension. Eur Heart J 2013;34:3649-3656. Go to original source... Go to PubMed...
  26. Kim JH, Noseworthy PA, McCarty D, et al. Significance of electrocardiographic right bundle branch block in trained athletes. Am J Cardiol 2011;107:1083-1089. Go to original source... Go to PubMed...
  27. Corrado D, Drezner JA, D'Ascenzi F, Zorzi A. How to evaluate premature ventricular beats in the athlete: critical review and proposal of a diagnostic algorithm [published online ahead of print, 2019 Sep 3]. Br J Sports Med 2019;bjsports-2018-100529. doi: 10.1136/bjsports-2018-100529 Go to original source... Go to PubMed...
  28. Biffi A, Maron BJ, Culasso F, et al. Patterns of ventricular tachyarrhythmias associated with training, deconditioning and retraining in elite athletes without cardiovascular abnormalities. Am J Cardiol 2011;107:697-703. Go to original source... Go to PubMed...
  29. Pelliccia A, Caselli S, Sharma S, et al. European Association of Preventive Cardiology (EAPC) and European Association of Cardiovascular Imaging (EACVI) joint position statement: recommendations for the indication and interpretation of cardiovascular imaging in the evaluation of the athlete's heart. Eur Heart J 2018;39:1949-1969. Go to original source... Go to PubMed...
  30. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015;16:233-270. Go to original source... Go to PubMed...
  31. Towbin JA, McKenna WJ, Abrams DJ, et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary. Heart Rhythm 2019;16:e373-e407. Go to original source... Go to PubMed...
  32. Sattar Y, Abdullah HM, Neisani Samani E, et al. Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An Updated Review of Diagnosis and Management. Cureus 2019;11:e5381. Go to original source... Go to PubMed...
  33. Ruwald AC, Marcus F, Estes NA, 3rd, et al. Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy. Eur Heart J 2015;36:1735-1743. Go to original source... Go to PubMed...
  34. Corrado D, Zorzi A. Arrhythmogenic right ventricular cardiomyopathy and sports activity. Eur Heart J 2015;36:1708-1710. Go to original source... Go to PubMed...
  35. Saberniak J, Hasselberg NE, Borgquist R, et al. Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members. Eur J Heart Fail 2014;16:1337-1344. Go to original source... Go to PubMed...
  36. Pelliccia A, Solberg EE, Papadakis M, et al. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis:position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC). Eur Heart J 2019;40:19-33. Go to original source... Go to PubMed...
  37. Pelliccia A, Fagard R, Bjornstad HH, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005;26:1422-1445. Go to original source... Go to PubMed...
  38. Maron BJ, Udelson JE, Bonow RO, et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation 2015;132:e273-e280. Go to original source... Go to PubMed...
  39. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 2010;121:1533-1541. Go to original source... Go to PubMed...
  40. Maury P, Rollin A, Sacher F, et al. Prevalence and prognostic role of various conduction disturbances in patients with the Brugada syndrome. Am J Cardiol 2013;112:1384-1389. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.